Toggle light / dark theme

OneSkin Technologies is a longevity company started by a team of incredible female PHDs and entrepreneurs, who have been using cutting edge technology to identify the senescent cells that cause your skin to age.
⠀⠀⠀
Discover how they use key peptide molecules to eliminate those senescent cells, making you look and feel 10 years younger.

Subscribe for Peter’s latest tech insights & updates: https://www.diamandis.com/subscribe

Using the Crispr gene-editing technique that won a recent Nobel Prize, Crispr Therapeutics cleared blood cancers in patients with off-the-shelf immune cells. These so-called CAR-T therapies previously required a patient’s own cells.

In a Wednesday morning announcement, Crispr Therapeutics (ticker: CRSP) said that its gene-editing let doctors use cells from healthy donors—opening up prospects for broadly available, less-expensive use of CAR-T treatment.

In the Phase 1 trial, the lymphoma blood cancer in four of 11 patients responded completely to infusions of T cells whose genes were altered to target the cancer and prevent transplant rejection. Standard treatments had failed all participants. In patients that got higher doses, the complete responses have lasted for months.